You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 7,659,282


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,659,282
Title:Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
Abstract:Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine.
Inventor(s): Yakatan; Gerald (Del Mar, CA), Berg; James (San Diego, CA), Pope; Laura E. (Carlsbad, CA), Smith; Richard A. (La Jolla, CA)
Assignee: Avanir Pharmaceuticals, Inc. (Aliso Viejo, CA)
Application Number:11/035,213
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,659,282
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 7,659,282

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Avanir Pharms NUEDEXTA dextromethorphan hydrobromide; quinidine sulfate CAPSULE;ORAL 021879-001 Oct 29, 2010 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up TREATMENT OF PSEUDOBULBAR AFFECT ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,659,282

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1539166 ⤷  Sign Up C300626 Netherlands ⤷  Sign Up
European Patent Office 1539166 ⤷  Sign Up CR 2013 00059 Denmark ⤷  Sign Up
European Patent Office 1539166 ⤷  Sign Up CA 2013 00059 Denmark ⤷  Sign Up
European Patent Office 1539166 ⤷  Sign Up C20130030 00105 Estonia ⤷  Sign Up
European Patent Office 1539166 ⤷  Sign Up 92323 Luxembourg ⤷  Sign Up
European Patent Office 1539166 ⤷  Sign Up 13C0062 France ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.